Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA.
Department of Bioinformatics and Computational Biology and The Proteomics and Metabolomics Core Facility, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Sci Rep. 2019 Jul 30;9(1):11070. doi: 10.1038/s41598-019-46432-0.
Active sites of enzymes are highly optimized for interactions with specific substrates, thus binding of opportunistic ligands is usually observed only in the absence of native substrates or products. However, during growth of crystals required for structure determination enzymes are often exposed to conditions significantly divergent from the native ones, leading to binding of unexpected ligands to active sites even in the presence of substrates. Failing to recognize this possibility may lead to incorrect interpretation of experimental results and to faulty conclusions. Here, we present several examples of binding of a citrate anion to the active sites of E. coli L-asparaginases I and II, even in the presence of the native substrate, L-Asn. A part of this report focuses on a comprehensive re-interpretation of structural results published previously for complexes of type I L-asparaginase (EcAI) from E. coli. In two re-refined structures a citrate anion forms an acyl-enzyme reaction intermediate with the catalytic threonine. These results emphasize the importance of careful and critical analysis during interpretation of crystallographic data.
酶的活性部位经过高度优化,可与特定的底物相互作用,因此只有在没有天然底物或产物的情况下,才会观察到机会性配体的结合。然而,在为确定结构而生长晶体的过程中,酶经常会暴露在与天然状态显著不同的条件下,导致即使在存在底物的情况下,也会有意外的配体结合到活性部位。如果未能认识到这种可能性,可能会导致对实验结果的不正确解释和错误的结论。在这里,我们展示了几个例子,即在存在天然底物 L-Asn 的情况下,柠檬酸阴离子结合到大肠杆菌 L-天冬酰胺酶 I 和 II 的活性部位。本报告的一部分重点是对先前发表的 I 型 L-天冬酰胺酶(EcAI)与柠檬酸阴离子形成的复合物的结构结果进行全面重新解释。在重新精修的两个结构中,柠檬酸阴离子与催化苏氨酸形成酰-酶反应中间体。这些结果强调了在解释晶体学数据时进行仔细和批判性分析的重要性。